Nasdaq 100 Sinks as Fed Weighs Quicker Taper Timeline; Omicron Provides to Market Worries


  • U.S. shares plunge as Fed Chair alerts help faster taper of asset purchases program
  • Nasdaq 100 slides 1.42% whereas the S&P 500 plunges 1.9%
  • Covid-19 omicron variant fears seem to bolster the unfavorable market sentiment

Most learn: How Will the Omicron Variant Impact Markets?

U.S. shares suffered heavy losses on Tuesday, weighed down by coronavirus issues, however mainly by indications that the Federal Reserve might pace up the pullback in stimulus to counter mounting inflationary forces. On the market shut, the S&P 500 tanked 1.9% to 4,567, whereas the Dow Jones tumbled 1.85% to 34,484. In the meantime, the Nasdaq 100 sank1.42% to 16,145, as Fb, Alphabet, Microsoft, and Amazon got here beneath intense promoting strain.

Yesterday I warned that increased uncertainty amid renewed pandemic worries might bias shares decrease within the close to time period as traders trim their publicity to threat property. This concern has materialized to some extent after Moderna’s CEO predicted that current vaccines will provide less protection towards the COVID-19 omicron variant first detected in Africa.

The unfavorable market tone was notably exacerbated by feedback made by Fed Chairman Powell at a congressional listening to. In his look earlier than the U.S. Senate Banking Committee, Powell acknowledged that the time has come to retire the phrase “transitory” when describing inflation and that it might be acceptable to wrap up the taper plan a number of months sooner than deliberate to handle elevated value pressures.

The central financial institution is lowering quantitative easing at a clip of $15 billion monthly. At that tempo, the bond-buying tapering scheme will conclude in June 2022, but when the establishment had been to speed up the part out course of, this system might finish someday within the spring, a state of affairs that might enable policymakers to lift borrowing prices sooner than anticipated. It is a main headwind for equities, notably these with exorbitant valuations (tech and progress shares for instance).

Heading into December, the Fed pivot and coronavirus worries might act as bearish catalysts for shares. Specializing in the latter, there are nonetheless many unknowns in regards to the omicron variant, however we must always be taught extra within the coming weeks after scientists conduct intensive epidemiological research. If the brand new pressure of the virus doesn’t trigger critical sickness and stays delicate to current vaccines, Wall Road might stage an explosive rally, but when the other is true, shares, particularly these linked to the reopening of the financial system, might be in for a significant sell-off earlier than the top of the yr.


The Nasdaq 100 made a pointy flip decrease on Tuesday after failing to clear resistance close to 16,450. If dip-buyers don’t pounce on the chance in coming classes, we might see a transfer in the direction of channel help close to 15,900, although a drop beneath this flooring might set the stage for a pullback in the direction of the 50-day transferring common, now crossing the 15,585 space.

However, if patrons resurface and the index pivots larger, the primary technical resistance to contemplate seems at 16,450. If this ceiling is taken out, the Nasdaq 100 might try and retest its report excessive at 16,765.


Nasdaq 100 Sinks as Fed Weighs Faster Taper Timeline; Omicron Adds to Market Worries

Nasdaq 100 (NDX) chart prepared in TradingView


  • Are you simply getting began? Obtain the learners’ guide for FX traders
  • Would you prefer to know extra about your buying and selling character? Take the DailyFX quiz and discover out
  • IG’s shopper positioning knowledge offers useful data on market sentiment. Get your free guide on the best way to use this highly effective buying and selling indicator right here.

—Written by Diego Colman, Contributor

Source link

Leave a Reply

Your email address will not be published.